With the FDA approval of Foundayo (orforglipron) in April 2026, Eli Lilly now offers two powerful GLP-1 medications for chronic weight management: the once-daily oral tablet, Foundayo, and the once-weekly injection, Zepbound (tirzepatide).
Both medications work by mimicking gut hormones to reduce appetite, slow gastric emptying, and promote feelings of fullness. However, they differ in how they are taken and in weight loss results.
This article provides a clear head-to-head comparison of Foundayo vs. Zepbound, including their efficacy, side effects, cost, and the clinical trial data on weight loss to help you decide which option best suits your needs.
What Is Foundayo?
Foundayo (orforglipron) is the newest oral glucagon-like peptide-1 (GLP-1) receptor agonist from Eli Lilly. It’s approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity such as high blood pressure, type 2 diabetes, or high cholesterol.
Foundayo is currently the only GLP-1 receptor agonist available as a daily pill that can be taken any time of day, with or without food, and without water restrictions. It is meant to be used alongside a reduced-calorie diet and exercise.
What Is Zepbound?
Zepbound (tirzepatide) is a once-weekly injectable medication from Eli Lilly, also approved by the FDA for chronic weight management. It is also FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity.
Zepbound contains tirzepatide, a dual agonist that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. Like Foundayo, it’s also used along with diet and exercise.
How do Foundayo and Zepbound work for weight loss?
Both Foundayo and Zepbound belong to the incretin mimetic class of medications. They mimic natural gut hormones that regulate appetite, digestion, and blood sugar levels, but do so in different ways.
Foundayo contains orforglipron, a GLP-1 receptor agonist. It works by activating GLP-1 receptors in your body, which promotes weight loss by:
- Reducing appetite and cravings, so you eat less.
- Slowing gastric emptying, so food stays in your stomach longer, helping you feel satisfied after smaller meals.
- Supports better blood sugar regulation.
Zepbound contains tirzepatide, a dual agonist that activates two gut hormones: GLP-1 and GIP receptors.
This dual mechanism provides:
- Stronger appetite suppression and reduced food cravings
- Greater slowing of gastric emptying and prolonged satiety.
- Improved metabolic benefits, including better insulin sensitivity.
The dual action is the main reason Zepbound is thought to produce higher average weight loss than single GLP-1 medications like Wegovy.
Foundayo vs. Zepbound: Which Is More Effective for Weight Loss?
According to current clinical trial data, Zepbound (tirzepatide) delivers greater average weight loss than Foundayo (orforglipron). However, individual results can vary, and there is still no direct head-to-head study comparing the two medications.
In Phase 3 trials for Foundayo, adults with obesity or overweight, with or without type 2 diabetes, achieved average weight reductions of 5.1% to 11.1% of baseline body weight after 72 weeks of treatment—higher doses produced better outcomes.
In adults without type 2 diabetes, the highest dose, 17.2 mg daily, led to an average of 11.1% weight loss (about 25 lbs / 11.3 kg), compared to just 2.1% in the placebo group. In those with type 2 diabetes, the average was 9.6%.
In the SURMOUNT-1 trial for Zepbound, adults with obesity or overweight without diabetes lost an average of 15.0% with the 5 mg weekly injection, 19.5% with the 10 mg dose, and 20.9% with the 15 mg dose.
Foundayo vs. Zepbound: Dosing and Administration
Another difference between Foundayo and Zepbound is how you take them. Foundayo is a daily oral pill, while Zepbound is a once-weekly injection.
Foundayo can be taken at any time of day, with or without food. You swallow the pill whole with water; you shouldn’t crush, split, or chew it.
Foundayo is started at a low dose and is slowly increased every 30 days until reaching the maintenance dose of up to 17.2 mg daily. This is to help your body adjust and to reduce gastrointestinal side effects.
Foundayo comes in six dosage strengths:
- 0.8 mg once daily
- 2.5 mg once daily
- 5.5 mg once daily
- 9 mg once daily
- 14.5 mg once daily
- 17.2 mg once daily (maintenance dose)
Zepbound is administered as a once-weekly subcutaneous injection using a pre-filled pen. It can be injected on the same day each week, at any time of day, with or without meals. It also starts low and is titrated up every 4 weeks as tolerated, with common maintenance doses of 5 mg, 10 mg, or 15 mg weekly.
Zepbound comes in six dosage strengths:
- 2.5 mg once weekly
- 5 mg once weekly
- 7.5 mg once weekly
- 10 mg once weekly
- 12.5 mg once weekly
- 15 mg once weekly
Here is a clear side-by-side comparison of the titration schedules for both medications:
| Week | Foundayo (Daily Dose) | Zepbound (Weekly Dose) |
| Weeks 1–4 | 0.8 mg once daily | 2.5 mg once weekly |
| Weeks 5–8 | 2.5 mg once daily | 5 mg once weekly |
| Weeks 9–12 | 5.5 mg once daily | 7.5 mg once weekly |
| Weeks 13–16 | 9 mg once daily | 10 mg once weekly |
| Weeks 17–20 | 14.5 mg once daily | 12.5 mg once weekly |
| Week 21 and beyond | 17.2 mg once daily (Maintenance) | 15 mg once weekly (Maintenance) |
It’s important to note that Foundayo titration may occur around every 30 days, while Zepbound titration may occur every 4 weeks (28 days).
Foundayo vs. Zepbound: Side Effects and Safety
Since Foundayo and Zepbound are GLP-1 receptor agonists, they share similar side effects. Most side effects are gastrointestinal and tend to be mild to moderate. They are most common when starting treatment and during dose increases, often improving as your body adjusts.
Common side effects of Zepbound and Foundayo include:
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Indigestion
- Abdominal Pain
- Bloating
- Headache
- Fatigue
- Belching
- Heartburn
- Gas
- Hair loss
While not common, these medications may cause serious side effects and risks, including:
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems
- Acute kidney injury, usually related to dehydration from GI side effects
- Severe gastrointestinal reactions
- Hypoglycemia (low blood sugar)
- Allergic reactions
Both medications carry an important boxed warning about the risk of thyroid C-cell tumors. This is as seen in animal studies, but not established in humans. Do not use any of the medication if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Foundayo vs. Zepbound: Cost Comparison
Foundayo is generally more affordable for cash-paying patients, especially at lower and mid-range doses. Without insurance, Foundayo costs:
- Starting dose (0.8 mg): $149 per month
- Mid doses (2.5 mg–9 mg): $199–$299 per month
- Higher/maintenance doses (14.5 mg – 17.2 mg): $299 – $349 per month
Zepbound costs around $299 to $449 per month for self-pay patients using Eli Lilly’s direct-to-consumer vials or KwikPen, depending on the dosage. While the official retail list price is over $1,000, Lilly reduced costs for those without insurance, with lower doses (2.5 mg) starting at roughly $299 and higher doses around $449.
With commercial insurance and a savings card, many patients pay as low as $25 per month for either Foundayo or Zepbound.
Medicare Part D coverage for weight-loss medications remains limited, but when available, copays may average around $50 per month for Foundayo. Zepbound coverage varies more widely.
Foundayo vs Zepbound: Comparison Table
| Category | Foundayo (Orforglipron) | Zepbound (Tirzepatide) |
| Active Ingredient | Orforglipron | Tirzepatide |
| Mechanism of Action | Single GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| Form & Dosing | Daily oral pill | Weekly subcutaneous injection |
| Frequency | Once daily | Once weekly |
| Average Weight Loss | 11.1% – 12.4% (at 72 weeks) | 15% – 20.9% (at 72 weeks) |
| Storage | Room temperature | Requires refrigeration |
| Can be taken with food | Yes (anytime) | Yes |
| Common Side Effects | Nausea, diarrhea, constipation, vomiting | Nausea, diarrhea, constipation, vomiting |
| Cash Price | $149 – $349 per month | $299 – $449 per month (vials) |
Foundayo vs. Zepbound: Which One Should You Choose?
Choosing between Foundayo and Zepbound comes down to your personal priorities, lifestyle, budget, and weight loss goals. There is no single best medication. Only the one that fits you best.
Choose Foundayo if:
- You dislike injections
- You travel frequently or have an unpredictable schedule
- You prefer the convenience of a simple daily pill with no refrigeration or special storage
- You want a lower monthly cost when paying cash
- You’re looking for a gentler introduction to GLP-1 medications
Choose Zepbound if:
- Your primary goal is maximum weight loss
- You have a higher starting BMI or obesity-related conditions, such as obstructive sleep apnea (OSA)
- You prefer dosing only once a week instead of every day
- You’re comfortable with self-injections
- You have good insurance coverage or qualify for strong savings programs
- You’ve tried a single GLP-1 medication before and didn’t get enough results
Foundayo vs. Zepbound: Can You Switch Between Them?
Yes, it is possible to switch between Foundayo and Zepbound, but it should always be done under the guidance of a qualified healthcare provider. If you’re switching from Zepbound to Foundayo, it requires a careful washout period or spacing period based on the prior drug’s half‑life. Your provider may recommend stopping Zepbound and starting Foundayo at a low dose after a short break.
If you’re switching from Foundayo to Zepbound, probably because you’ve plateaued on Foundayo and want stronger results, your healthcare provider can start Zepbound at a moderate dose, maybe 5 mg, rather than the lowest starting dose, depending on your current Foundayo dose and tolerance.
Foundayo vs. Zepbound: Can You Take Them Together?
No, you should not take Foundayo and Zepbound together. Both drugs work through the same GLP-1 pathway. Taking them simultaneously can lead to excessive GLP-1 receptor activation, increasing the risk and severity of side effects.
FAQs about Foundayo vs. Zepbound
Can I switch from Zepbound to Foundayo?
Yes, you can switch from Zepbound to Foundayo, but it should be done under medical supervision. Your provider will create a safe transition plan with proper dosing and monitoring.
Is Foundayo the same as Zepbound?
No, Foundayo and Zepbound are not the same. Foundayo is a daily oral GLP-1 pill, while Zepbound is a weekly injection that works on two receptors, GLP-1 and GIP. Zepbound is stronger for weight loss, while Foundayo offers better convenience.
Which works better for weight loss: Foundayo or Zepbound?
Zepbound works better for weight loss. In clinical trials, Zepbound produced a higher average weight loss of up to 20.9% compared to Foundayo’s 12.4%. However, individual results vary based on lifestyle, adherence, and tolerance.
How much does Foundayo cost compared to Zepbound?
Foundayo is usually more affordable when paying cash, ranging from $149 to $349 per month. Zepbound cash prices range from $299–$449 per month (vials). With insurance and savings cards, both can drop to as low as $25 per month.
Can Foundayo be taken with food?
Yes, Foundayo can be taken with or without food. You can take the pill at any time that suits your routine.
What are the side effects of Foundayo vs. Zepbound?
Both have similar side effects, mainly gastrointestinal issues like nausea, diarrhea, vomiting, and constipation. These are usually worse during dose increases. Most side effects improve over time with both medications.
Is Foundayo available through telehealth?
Yes, Foundayo is available through telehealth. At NP2GO, our nurse practitioners can evaluate you via virtual consultation and prescribe Foundayo if appropriate. We serve patients across 38+ U.S. states.
Foundayo or Zepbound: Which One Is Right for You?
Choosing between Foundayo and Zepbound depends on your personal priorities.
If convenience, needle-free dosing, and affordability matter most to you, Foundayo may be a good option. However, if you’re looking for maximum weight loss and are comfortable with weekly injections, Zepbound remains the stronger option based on current clinical data.
Both medications can be highly effective when paired with the right support.
At NP2GO, we specialize in helping patients make the most personalized decisions. Our experienced healthcare providers will assess your health goals, lifestyle, budget, and medical history to recommend the most suitable option, whether it’s the new oral GLP-1 pill, Foundayo, or the dual agonist Zepbound.
Book your personalized telehealth consultation today to get expert guidance and ongoing support from licensed providers.